Biomarkers in pancreatic adenocarcinoma: current perspectives

Douglas S Swords, Matthew A Firpo, Courtney L Scaife, Sean J Mulvihill Department of Surgery, University of Utah Health Sciences, Salt Lake City, UT, USA Abstract: Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year survival rate of 7.7%. Most patients are diagnose...

Full description

Bibliographic Details
Main Authors: Swords DS, Firpo MA, Scaife CL, Mulvihill SJ
Format: Article
Language:English
Published: Dove Medical Press 2016-12-01
Series:OncoTargets and Therapy
Subjects:
CEA
Online Access:https://www.dovepress.com/biomarkers-in-pancreatic-adenocarcinoma-current-perspectives-peer-reviewed-article-OTT